$4.710
-0.255 (-5.42%)Zum Schluss
Umsatzquellen von VSTA
Vasta Platform Ltd (VSTA) generates its revenue through a diversified portfolio of business segments. Currently, the largest contributor to its top-line growth is Content & EdTech Platform, accounting for 93.6% of total sales, equivalent to BRL 254.04M. Another important revenue stream is Digital Platform. Understanding this composition is critical for investors evaluating how VSTA navigates market cycles within the Miscellaneous Educational Service Providers industry.
Profitabilität und Margen von VSTA
Evaluating the bottom line, Vasta Platform Ltd maintains a gross margin of 67.92%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at -15.59%, while the net margin is -23.91%. These profitability ratios, combined with a Return on Equity (ROE) of 10.54%, provide a clear picture of how effectively VSTA converts its operational activities into shareholder value.
VSTA im Vergleich zur Peergroup
In the context of the broader market, VSTA competes directly with industry leaders such as API and SMWB. With a market capitalization of N/A, it holds a significant position in the sector. When comparing efficiency, VSTA's gross margin of 67.92% stands against API's 63.67% and SMWB's 80.73%. Such benchmarking helps identify whether Vasta Platform Ltd is trading at a premium or discount relative to its financial performance.
Finanzielle Entwicklung von Vasta Platform Ltd
Latest reported quarter: 2025/Q3. Revenue increased to 249.602M (+13.36% YoY), indicating continued top-line growth. However, net income worsened to -59.77M (-22.52% YoY) and EPS declined to -0.74 (-19.57% YoY), meaning losses deepened despite stronger revenue. Gross margin rose to 67.92% (+7.59% YoY), which is a positive efficiency indicator, but it has not translated into bottom-line improvement yet.
Financials
Diese Seite dient nur der Recherche und ist keine Anlageberatung. Modelle können falsch liegen. Vergangene Wertentwicklung ist kein Indikator für die Zukunft.